BioHealth News

Altimmune to Host Virtual R&D Day on March 13, 2025

Altimmune to Host Virtual R&D Day on March 13, 2025

GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D…

Read More
WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 5, 2025 - A New York health care technology company that recently adopted a…

Read More
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared…

Read More
Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering,…

Read More
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients  Rockville, MD – The U.S. Pharmacopeia (USP)…

Read More
TEDCO Invests in Irazú Oncology

TEDCO Invests in Irazú Oncology

Life sciences company developing a cost-effective production process for cancer immunotherapies COLUMBIA, Md., (March 5, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a…

Read More
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the…

Read More
IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence…

Read More
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its industry leading…

Read More
Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

Venture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money

Since I have been raising and deploying a venture fund focused on addressing health of women lately, I have had numerous occasions to be in rooms…

Read More
BioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem

BioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem

By Annabel Baldy - In November’s What’s the Buzz?! LinkedIn Live session, Chris Frew, CEO of BioBuzz and Tammi Thomas, Chief Development & Marketing Officer, TEDCO…

Read More
GEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades

GEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades

By Kevin Davies, PhD - March 3, 2025 - After an illustrious career including 12 years as director of the National Institutes of Health…

Read More
GEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate

GEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate

By Alex Philippidis - February 26, 2025 - The FDA has granted Priority Review to Precigen’s Biologics License Application (BLA) for its lead candidate…

Read More
TNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty

TNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty

BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory…

Read More
CityBiz – Protenus: From Accelerator to Acquisition

CityBiz – Protenus: From Accelerator to Acquisition

Protenus, a leading healthcare compliance analytics platform that serves over 200 healthcare organizations, was acquired in January 2025 by Bluesight, a prominent provider of inventory management, procurement,…

Read More